NASDAQ : MEDS
DataMEDS AI, Inc. — Financial statements
Healthcare · Pharmaceutical Retailers · United States
Last price 1.92 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.88M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
DataMEDS AI, Inc. (MEDS) reported revenue of 8.02M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 8.02M | 23.34M | 18.13M | ||
| Cost of Revenue | 15.30M | 29.76M | 16.36M | ||
| Gross Profit | -7.27M | -6.43M | 1.77M | ||
| Selling, General & Admin | 48.12M | 71.56M | 6.80M | 2.88M | 15.75K |
| Operating Expenses | 50.43M | 74.77M | 7.91M | 2.88M | 15.75K |
| Operating Income | -57.71M | -81.19M | -6.15M | -2.88M | -15.75K |
| Interest Expense | -5.93M | -4.58M | -831.47K | -15.08K | |
| Other Non Operating Income (Expenses) | 628.03K | 42.05K | 120.37K | ||
| EBT Excluding Unusual Items | -63.01M | -85.73M | -6.86M | -2.90M | -15.75K |
| Impairment of Goodwill | -2.03M | -2.03M | |||
| Asset Writedown | -10.53M | -10.53M | |||
| Other Unusual Items | -12.70M | -2.99M | |||
| Pretax Income | -88.28M | -101.27M | -6.86M | -2.90M | -15.75K |
| Net Income | -88.28M | -101.27M | -6.86M | -2.90M | -15.75K |
| Net Income to Common | -88.28M | -101.27M | -6.86M | -2.90M | -15.75K |
| Shares Outstanding (Basic) | 2.02M | 1.42M | 945.04K | 894.40K | |
| Shares Outstanding (Diluted) | 2.02M | 1.42M | 945.04K | 894.40K | |
| EPS (Basic) | -43.73 | -71.33 | -7.25 | -3.24 | |
| EPS (Diluted) | -43.73 | -71.33 | -7.25 | -3.24 | |
| Gross Margin | -90.64% | -27.54% | 9.75% | ||
| Operating Margin | -719.27% | -347.91% | -33.90% | ||
| Profit Margin | -1,100.30% | -433.95% | -37.82% | ||
| EBITDA | -55.39M | -77.98M | -5.03M | ||
| EBITDA Margin | -27.75% | ||||
| D&A For EBITDA | 2.32M | 3.21M | 1.11M | ||
| EBIT | -57.71M | -81.19M | -6.15M | -2.88M | -15.75K |
| EBIT Margin | -33.90% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.46M | 42.57K | 1.03M | 1.36K | |
| Cash & Short-Term Investments | 2.46M | 42.57K | 1.03M | 1.36K | |
| Accounts Receivable | 1.17M | 1.14M | 2.72M | ||
| Other Receivables | 26.07K | 1.02M | 337.00K | ||
| Receivables | 1.20M | 1.14M | 3.75M | 337.00K | |
| Inventory | 1.51M | 1.64M | 9.52M | ||
| Prepaid Expenses | 465.74K | 524.00 | |||
| Other Current Assets | 875.38K | ||||
| Total Current Assets | 5.63M | 2.82M | 15.17M | 338.36K | |
| Property, Plant & Equipment | 893.52K | 1.20M | 1.92M | ||
| Goodwill | 14.19M | 14.19M | 16.22M | ||
| Other Intangible Assets | 11.95M | 12.17M | 22.36M | ||
| Other Long-Term Assets | 85.01K | 85.01K | 1.52M | ||
| Total Assets | 32.76M | 30.46M | 57.33M | 338.36K | |
| Accounts Payable | 12.64M | 11.69M | 6.33M | 1.04M | 5.25K |
| Accrued Expenses | 6.81M | 5.74M | 3.96M | 1.78M | |
| Short-Term Debt | 3.24M | 5.67M | |||
| Current Portion of Long-Term Debt | 19.21M | 7.64M | 6.26M | ||
| Current Portion of Leases | 566.38K | 569.25K | 519.49K | ||
| Current Unearned Revenue | 26.00K | 488.23K | 245.76K | ||
| Other Current Liabilities | 166.29K | 408.94K | 15.05M | 67.79K | |
| Total Current Liabilities | 39.41M | 29.78M | 38.05M | 2.89M | 5.25K |
| Long-Term Debt | 12.60M | 12.60M | 11.46M | 350.00K | |
| Long-Term Leases | 249.84K | 527.12K | 1.10M | ||
| Total Liabilities | 52.26M | 42.91M | 50.60M | 3.24M | 5.25K |
| Common Stock | 283.00 | 10.13K | 5.11K | 4.47K | |
| Additional Paid-In Capital | 117.63M | 98.57M | 16.49M | ||
| Retained Earnings | -137.14M | -111.03M | -9.76M | -2.90M | -5.25K |
| Comprehensive Income & Other | -3.97K | ||||
| Shareholders' Equity | -19.50M | -12.45M | 6.73M | -2.90M | -5.25K |
| Total Liabilities & Equity | 32.76M | 30.46M | 57.33M | 338.36K | |
| Total Debt | 32.62M | 24.58M | 25.00M | 350.00K | |
| Net Cash (Debt) | -30.17M | -24.54M | -23.97M | -348.64K | |
| Net Cash Per Share | -14.94 | -17.29 | -25.36 | -0.39 | |
| Filing Date Shares Outstanding | 3.06M | 2.10M | 1.04M | ||
| Total Common Shares Outstanding | 2.84M | 2.03M | 1.02M | ||
| Working Capital | -33.78M | -26.96M | -22.88M | -2.55M | -5.25K |
| Book Value Per Share | -6.88 | -6.14 | 6.60 | ||
| Tangible Book Value | -45.65M | -38.81M | -31.85M | -2.90M | -5.25K |
| Tangible Book Value Per Share | -16.09 | -19.15 | -31.19 | ||
| Machinery | 741.37K | 741.37K | 741.37K | ||
| Leasehold Improvements | 766.47K | 766.47K | 766.47K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -88.28M | -101.27M | -6.86M | -2.90M | -15.75K |
| Depreciation & Amortization | 2.32M | 3.21M | 1.11M | ||
| Other Amortization | 11.22M | 33.41K | |||
| Asset Writedown & Restructuring Costs | 13.99M | 13.99M | |||
| Stock-Based Compensation | 28.65M | 54.79M | 1.08M | ||
| Provision & Write-off of Bad Debts | 940.93K | 927.60K | 93.38K | ||
| Other Operating Activities | 9.88M | 8.98M | |||
| Change in Accounts Receivable | 185.96K | 799.77K | -40.08K | ||
| Change in Inventory | 1.46M | 1.89M | -72.36K | ||
| Change in Accounts Payable | 1.49M | 2.20M | -882.32K | 1.03M | 15.75K |
| Change in Other Net Operating Assets | 4.41M | 3.60M | 4.34M | 1.51M | |
| Operating Cash Flow | -13.74M | -10.86M | -1.22M | -349.14K | |
| Cash Acquisitions | 931.37K | ||||
| Sale (Purchase) of Intangibles | -923.70K | -881.53K | -377.29K | ||
| Other Investing Activities | -85.01K | ||||
| Investing Cash Flow | -923.70K | -881.53K | 469.07K | ||
| Short-Term Debt Issued | 20.93M | 756.48K | |||
| Long-Term Debt Issued | 3.22M | 1.31M | 350.00K | ||
| Total Debt Issued | 19.65M | 24.15M | 2.07M | 350.00K | |
| Short-Term Debt Repaid | -24.09M | -135.78K | |||
| Long-Term Debt Repaid | -2.17M | ||||
| Total Debt Repaid | -11.30M | -26.26M | -135.78K | ||
| Net Debt Issued (Repaid) | 8.35M | -2.11M | 1.94M | 350.00K | |
| Issuance of Common Stock | 9.10M | 13.67M | 10.00K | 500.00 | |
| Other Financing Activities | -759.59K | -810.58K | -162.31K | ||
| Financing Cash Flow | 16.70M | 10.75M | 1.78M | 350.50K | |
| Net Cash Flow | 2.04M | -985.76K | 1.03M | 1.36K | |
| Levered Free Cash Flow | 2.37M | 7.64M | 6.37M | ||
| Unlevered Free Cash Flow | -5.15M | 10.46M | 6.89M | ||
| Cash Interest Paid | 2.15M | 3.11M | 332.85K | ||
| Change in Working Capital | 7.54M | 8.48M | 3.34M | 2.55M | 15.75K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 5.30M | 40.08M | |||
| Enterprise Value | 35.46M | 61.83M | |||
| Last Close Price | 1.92 | 19.98 | |||
| PS Ratio | 0.73 | 1.72 | |||
| PB Ratio | -3.22 | ||||
| EV/Sales Ratio | 4.49 | 2.65 | |||
| Debt / Equity Ratio | -1.67 | -1.98 | 3.71 | -0.12 | |
| Net Debt / Equity Ratio | -1.55 | -1.97 | 3.56 | -0.12 | |
| Net Debt / EBITDA Ratio | -0.55 | -0.32 | -4.76 | ||
| Asset Turnover | 0.18 | 0.53 | 0.63 | ||
| Inventory Turnover | 2.90 | 5.33 | |||
| Quick Ratio | 0.09 | 0.04 | 0.12 | 0.12 | |
| Current Ratio | 0.14 | 0.10 | 0.40 | 0.12 | |
| Return on Equity (ROE) | -357.65% | ||||
| Return on Assets (ROA) | -82.93% | -115.61% | -13.32% | ||
| Return on Capital Employed (ROCE) | 867.20% | -11,952.40% | -31.90% | 112.90% | 300.00% |
| Earnings Yield | -2,527.52% | -252.65% | |||
| Buyback Yield / Dilution | -93.15% | -50.23% | -5.66% |